President & CEO of Biolife Solutions Inc (30-Year Financial, Insider Trades) Michael Rice (insider trades) sold 37,500 shares of BLFS on 08/13/2020 at an average price of $19.28 a share. The total sale was $723,000.
BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation. BioLife Solutions Inc has a market cap of $603.870 million; its shares were traded at around $18.87 with and P/S ratio of 11.35. BioLife Solutions Inc had annual average EBITDA growth of 10.70% over the past five years. GuruFocus has detected 3 severe warning signs with BioLife Solutions Inc. .
CEO Recent Trades:
-
President & CEO Michael Rice sold 37,500 shares of BLFS stock on 08/13/2020 at the average price of $19.28. The price of the stock has decreased by 2.13% since.
-
President & CEO Michael Rice sold 37,500 shares of BLFS stock on 07/16/2020 at the average price of $18.99. The price of the stock has decreased by 0.63% since.
Directors and Officers Recent Trades:
-
Exec VP & Chief Scientific Off Aby J. Mathew sold 15,000 shares of BLFS stock on 08/12/2020 at the average price of $19.91. The price of the stock has decreased by 5.22% since.
-
10% Owner Walter Villiger sold 100,000 shares of BLFS stock on 08/10/2020 at the average price of $21.32. The price of the stock has decreased by 11.49% since.
-
Exec VP & Chief Scientific Off Aby J. Mathew sold 10,000 shares of BLFS stock on 07/15/2020 at the average price of $19.48. The price of the stock has decreased by 3.13% since.
For the complete insider trading history of BLFS, click here
.This article first appeared on GuruFocus.